Guardant Health Inc. (GH) stock soared 5.08% in early trading on Wednesday, following a strong quarterly performance that prompted Piper Sandler to raise its price target on the company.
According to the news, Piper Sandler analyst David Westenberg raised the firm's price target on Guardant Health to $50 from $34, reflecting the company's solid financial results and positive outlook.
The stock price surge indicates investors' confidence in Guardant Health's prospects, as the company continues to innovate and expand its offerings in the healthcare sector.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.